Drusano GL, Rogers S, Brown D, Peloquin CA, et al. Dose-fractionation of moxifloxacin for the treatment of tuberculosis: impact of dosing interval and elimination half-life on microbial kill and resistance suppression. Antimicrob Agents Chemother 2021 Jan 19. pii: AAC.02533.
PMID: 33468465